Are you Christopher M. Pieczonka, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileChristopher M. Pieczonka, M.D. practices urology in Syracuse, NY. Christopher is a 1997 graduate of State University of New York at Buffalo School of Medicine. Medicare claims data shows Christopher provided 29,774 services to 2,979 patients. The services billed most often include injection, denosumab, 1 mg, leuprolide injectable, camcevi, 1 mg, and insertion of needle into vein for collection of blood sample. The provider's National Provider Identifier (NPI) is 1376530121.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
1226 E WATER ST
Syracuse, NY 13210
Within Urology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Bladder and urethra
Kidney and ureter
Male reproductive and sexual health
Prostate
Urinary symptoms and infection
Bladder & Urination
Kidney health
Men's health
Urinary symptoms
Most searched procedures
Office diagnosis
Bladder procedures
Diagnostic imaging
Kidney & ureter procedures
Kidney and ureter surgery
Male reproductive
Prostate
Prostate procedures
Stone procedures
29,774 services · 2,979 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
979 | More than most peers in Urology |
| Ultrasound measurement of bladder capacity after voiding | Procedure | 51798 |
63 | Less often than most peers in Urology |
| Diagnostic exam of bladder and urethra using an endoscope | Procedure | 52000 |
42 | Less often than most peers in Urology |
| Instillation of anti-cancer drug into bladder | Procedure | 51720 |
18 | Less often than most peers in Urology |
| Complete ultrasound scan behind abdominal cavity | Imaging | 76770 |
68 | As often as other peers in Urology |
| Limited ultrasound scan behind abdominal cavity | Imaging | 76775 |
39 | As often as other peers in Urology |
| Nuclear medicine study from skull base to mid-thigh with ct scan | Imaging | 78815 |
32 | As often as other peers in Urology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
183 | More often than most peers in Urology |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
144 | More than most peers in Urology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
19,560 | More than most peers in Urology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Christopher M. Pieczonka is an urologist in Syracuse, NY. That is the designation recorded for this NPI in the federal registry, where it is listed as “Urology”.
NPI registry
Christopher M. Pieczonka is listed at 1226 E Water St, Syracuse, NY 13210. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (315) 478-4185. Contact the office directly to confirm availability and scheduling.
NPI registry
Christopher M. Pieczonka's National Provider Identifier is 1376530121. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Christopher M. Pieczonka attended State University of New York at Buffalo School of Medicine, graduating in 1997. This comes from the CMS National Downloadable File.
CMS public data
Christopher M. Pieczonka has 29 years experience. Calculated from a graduation year of 1997, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Christopher M. Pieczonka performs procedures including insertion of needle into vein for collection of blood sample, ultrasound measurement of bladder capacity after voiding and diagnostic exam of bladder and urethra using an endoscope; reads or performs imaging such as complete ultrasound scan behind abdominal cavity and limited ultrasound scan behind abdominal cavity; provides treatments such as injection of drug or substance under skin or into muscle and administration of hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Christopher M. Pieczonka. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.